US2012136154A1PendingUtilityA1

Processes for the preparation of substituted tetrahydro beta-carbolines

50
Assignee: HWANG PETER SEONGWOOPriority: May 27, 2009Filed: May 27, 2010Published: May 31, 2012
Est. expiryMay 27, 2029(~2.9 yrs left)· nominal 20-yr term from priority
C07D 471/04
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are improved processes for the synthesis of substituted tetrahydro beta-carboline derivatives. In particular, provided herein are improved processes useful for the preparation of (S)-4-chlorophenyl 6-chloro-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4- b ]indole-2(9H)-carboxylate. Formula (I)

Claims

exact text as granted — not AI-modified
1 . A process for preparing a compound of Formula (II): 
       
         
           
           
               
               
           
         
         comprising the steps of:
 i) reacting a compound of Formula (IV) with a mixture of a chiral acid in a first solvent mixture: 
 
       
       
         
           
           
               
               
           
         
         and
 ii) recrystallizing the reaction product in a second solvent mixture to provide the compound of Formula (II), wherein
 X is halogen; and 
 R is substituted or unsubstituted C 1  to C 8  alkyl. 
 
 
       
     
     
         2 . The process of  claim 1 , wherein X is chloro. 
     
     
         3 . The process of  claim 1 , wherein R is C 1  to C 8  alkyl substituted with one or more substituents selected from halogen, hydroxyl or C 1  to C 8 alkoxy. 
     
     
         4 . The process of  claim 1 , wherein R is methyl. 
     
     
         5 . The process of  claim 1 , wherein X is chloro and R is methyl. 
     
     
         6 . The process of  claim 1 , wherein the first solvent mixture is a mixture of water and a solvent in a ratio in a range of from about 1 to about 5% volume/volume water:solvent. 
     
     
         7 . The process of  claim 6 , wherein the ratio of the first solvent mixture is in a range of from about 2 to about 5% volume/volume water:solvent. 
     
     
         8 . The process of  claim 7 , wherein the solvent in the first solvent mixture is methanol, ethanol, 1-propanol, 1-butanol or a mixture thereof. 
     
     
         9 . The process of  claim 8 , wherein the solvent in the first solvent mixture is methanol, ethanol or a mixture thereof. 
     
     
         10 . The process of  claim 9 , wherein the solvent in the first solvent mixture is ethanol. 
     
     
         11 . The process of  claim 1 , wherein the solvent in the second solvent mixture is a mixture of water and a solvent, wherein the solvent is iPrOAc, EtOAc, MTBE, MEK, DCM, DCE, toluene, DMA or a mixture thereof. 
     
     
         12 . The process of  claim 11 , wherein the solvent in the second solvent mixture is EtOAc or MEK or a mixture thereof. 
     
     
         13 . The process of  claim 12 , wherein the solvent in the second solvent mixture is MEK. 
     
     
         14 . A process for preparing a compound of Formula (II): 
       
         
           
           
               
               
           
         
         comprising the step of reacting about one equivalent of a compound of Formula (IV) with a chiral acid in a range of from about 0.1 to about 0.5 equivalents in a first solvent mixture comprising a mixture of ethanol and water in a ratio in a range of from about 1 to about 5% volume/volume water:ethanol: 
       
       
         
           
           
               
               
           
         
         to provide the compound of Formula (II), wherein
 X is halogen; and 
 R is substituted or unsubstituted C 1  to C 8  alkyl. 
 
       
     
     
         15 . The process of  claim 14 , wherein the chiral acid is about 0.5 equivalents. 
     
     
         16 . The process of  claim 14 , wherein the ratio of the first solvent mixture is in a range of from about 2 to about 5% volume/volume water:ethanol. 
     
     
         17 . A process for preparing a compound of Formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof: 
       
         
           
           
               
               
           
         
         comprising the steps of:
 i) reacting a compound of Formula (IV), with a chiral acid in a first solvent mixture: 
 
       
       
         
           
           
               
               
           
         
         
           to provide a compound of Formula (II), wherein
 X is halogen; and 
 R is substituted or unsubstituted C 1  to C 8  alkyl; and 
 
           ii) reacting the compound of Formula (II) with a compound of Formula (III) in the presence of a base and a second solvent mixture comprising water and a solvent: 
         
       
       
         
           
           
               
               
           
         
         
           to provide a compound of Formula (I), wherein 
           X is at each occurrence independently halogen; and 
           R is substituted or unsubstituted C 1  to C 8  alkyl. 
         
       
     
     
         18 . The process of  claim 17 , wherein the first solvent mixture is a mixture of water and a solvent in a ratio in a range of from about 1 to about 5% volume/volume water:solvent. 
     
     
         19 . The process of  claim 18 , wherein the ratio of the first solvent mixture is in a range of from about 2 to about 5% volume/volume water:solvent. 
     
     
         20 . The process of  claim 18 , wherein the solvent in the first solvent mixture is methanol, ethanol, 1-propanol, 1-butanol or a mixture thereof. 
     
     
         21 . The process of  claim 20 , wherein the solvent in the first solvent mixture is methanol, ethanol or a mixture thereof. 
     
     
         22 . The process of  claim 21 , wherein the solvent in the first solvent mixture is ethanol. 
     
     
         23 . The process of  claim 17 , wherein the solvent in the second solvent mixture is iPrOAc, EtOAc, MTBE, MEK, DCM, DCE, toluene, DMA or a mixture thereof. 
     
     
         24 . The process of  claim 23 , wherein the solvent in the second solvent mixture is EtOAc or MEK or a mixture thereof. 
     
     
         25 . The process of  claim 24 , wherein the solvent in the second solvent mixture is MEK. 
     
     
         26 . The process of  claim 1 , wherein a compound of Formula (I) is a compound of Formula (X): 
       
         
           
           
               
               
           
         
       
     
     
         27 . The process of  claim 1 , wherein the compound of Formula (II) is 
       
         
           
           
               
               
           
         
       
     
     
         28 . The process of any of  claim 1 ,  15  or  18 , wherein the chiral acid is N-acetyl-L-phenylalanine, (S)-2-(methoxycarbonylamino)-3-phenylpropanoic acid, (S)-2-(isopropoxycarbonylamino)-3-phenylpropanoic acid, (S)-2-benzamido-3-phenylpropanoic acid, (S)-2-(4-chlorobenzamido)-3-phenylpropanoic acid, (S)-2-(4-methoxybenzamido)-3-phenylpropanoic acid, (S)-3-phenyl-2-(4-(trifluoromethyl)benzamido)propanoic acid, (S)-2-isobutyramido-3-phenylpropanoic acid, (S)-3-phenyl-2-(phenylsulfonamido)propanoic acid, (S)-3-phenyl-2-(4-(trifluoromethyl)phenylsulfonamido)propanoic acid, (S)-2-(4-methoxyphenylsulfonamido)-3-phenylpropanoic acid or (S)-2-(4-methylphenylsulfonamido)-3-phenylpropanoic acid. 
     
     
         29 . The process of any of  claim 1 ,  15  or  18 , wherein the chiral acid is N-acetyl-L-phenylalanine. 
     
     
         30 . The process of  claim 1 , further comprising the step of preparing a compound of Formula (IV) by reacting a compound of Formula (V): 
       
         
           
           
               
               
           
         
         with a solvated base, wherein
 X is halogen, 
 R is substituted or unsubstituted C 1  to C 8  alkyl, and 
 HB is an acid suitable to form a salt with a compound of Formula (V). 
 
       
     
     
         31 . The process of  claim 30 , wherein HB is an acid suitable to form a salt with a compound of Formula (V), such as hydrochloric acid or acetic acid and the solvated base is aqueous ammonium hydroxide in a mixture with ethyl acetate or isopropyl acetate. 
     
     
         32 . The process of  claim 30 , further comprising the step of preparing a compound of Formula (V) by reacting a compound of Formula (VII): 
       
         
           
           
               
               
           
         
         with a compound of Formula (VI): 
       
       
         
           
           
               
               
           
         
         in the presence of a suitable acid in a suitable solvent, wherein
 X is halogen, 
 R is substituted or unsubstituted C 1  to C 8  alkyl, and 
 HB′ is an acid suitable to form a salt with the amino group of a compound of Formula (VII). 
 
       
     
     
         33 . The process of  claim 32 , wherein the suitable acid is hydrochloric acid, the solvent is water or EtOAc and HB′ is hydrochloric acid or acetic acid.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.